Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs.
The findings, published online in the Journal of Proteome Research, are significant because current newborn screening methods are not accurate enough to identify the disorder in the population, which can manifest itself in many different ways, requiring additional testing and causing further stress for anxious parents.
“The earlier CF is detected, the earlier it can be managed and treated, which means better health outcomes for affected infants, including their future growth and development,” says Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry & Chemical Biology, who conducted the research with graduate student Alicia DiBattista, now a postdoctoral fellow at Newborn Screening Ontario (NSO).
A tiny amount of blood is drawn from the heel of all babies as part of universal newborn screening programs that test for many rare yet treatable diseases since babies usually have no signs of disease at birth, including CF.
In the case of CF, infants are screened for a pancreatic enzyme and then a panel of disease-causing genetic mutations associated with CF. However, further testing to confirm or rule out the disease finds that most babies who screen-positive do not actually have the disease. These babies are later found to be “healthy carriers” or their results are deemed to be “false positives”.
With this in mind, researchers set out to determine whether they could discover chemical signatures in a dried blood spot that could better distinguish infants who have CF from those who do not.
Using less than a single drop of blood stored at NSO at CHEO, a pediatric health and research centre in Ottawa, researchers analyzed and compared samples from infants confirmed to have CF with the samples of both healthy and screen positive infants. They found several new compounds as well as simple amino acids directly related to affected infants with CF who otherwise have no symptoms and normal birth weight.
“These biomarkers provide new insights into the disease process early in life before symptoms are fully apparent,” says Britz-McKibbin. “Moreover, these compounds can be analyzed by mass spectrometry at incremental costs since it is already used for testing many other genetic diseases at newborn screening facilities around the world”
“Ontario started screening for Cystic Fibrosis in April 2007, and since that time over 400 children have already benefited from early recognition and early treatment. But for every one of these children, about 10 have had a false-positive result. We want to get this number down and are very hopeful that the new biomarkers discovered by this research project will help us do exactly that,” says Pranesh Chakraborty, medical director of NSO at CHEO.
In Canada, life expectancy rates have risen dramatically with the median age of survival now over 50 years, due to better treatments to improve lung function, better nutrition, lung transplants. The advent of universal newborn screening programs for CF will likely further improve the quality of life of affected patients.
“We know that early detection can have significant benefits for people living with cystic fibrosis,” said Dr. John Wallenburg, chief scientific officer at Cystic Fibrosis Canada. “The current screening methodologies capture a broad swathe of families that then need further testing to narrow down those that are true positives. The anxiety and distress that such further testing can needlessly cause families was a major concern that slowed the adoption of newborn screening in some jurisdictions. Dr. Britz-McKibbin’s data provide insights for more specific newborn screening, as well as early manifestations of the disease.”
The Latest on: Cystic fibrosis
via Google News
The Latest on: Cystic fibrosis
- Randy Sims Fights the Good Fight with Golfon December 7, 2021 at 1:48 pm
Sims Executive Search CEO admits that some days are a struggle after being diagnosed with Cystic Fibrosis at age 10, but golf has helped him through life's valleys.
- Old Bridge students again collecting letters to Santa for charityon December 7, 2021 at 7:36 am
Since then, Silvestri, an Old Bridge High School senior, has worked hard to ensure other children with life-threatening diseases can also have their wishes granted. A few years later, he joined forces ...
- Specific Biologics Inc. Announces Therapeutic Development Award from the Cystic Fibrosis Foundationon December 7, 2021 at 6:00 am
Specific Biologics Inc. ("Specific"), an early-stage biotechnology company developing novel gene editing technologies, today announced that it will receive more than US$527,000 to support the ...
- CF Foundation Awards More Than $1.8M to Three Companies for Genetic Therapies Researchon December 7, 2021 at 6:00 am
The Cystic Fibrosis Foundation announced today that it has awarded more than $1.8 million to three companies for early-stage research into potential genetic therapies for cystic fibrosis as part of ...
- CF Foundation Invests $3.5 Million in Pulmocide for Development of Novel Antifungal Treatment for Lung Transplant Recipientson December 6, 2021 at 5:03 am
Today, the Cystic Fibrosis Foundation announced its investment of $3.5 million in Pulmocide Limited, a U.K.-based biotech company, to develop an inhaled drug (opelconazole) to prevent Aspergillus ...
- Pulmocide Receives Investment from the Cystic Fibrosis Foundationon December 6, 2021 at 5:00 am
The Cystic Fibrosis Foundation invested $3.5 million in Pulmocide as part of the CF Foundation’s Lung Transplant InitiativeFunding supports prophylaxis study in lung transplant patients LONDON, Dec.
- Cystic Fibrosis campaigner Orla Tinsley on getting ‘gift of life’ with lung transplant and joy of running 5kon December 3, 2021 at 3:01 pm
CYSTIC Fibrosis campaigner Orla Tinsley has opened up about getting the “gift of life” with their double lung transplant – and the joy of being able to run 5k. Activist Orla ...
- MSU lab studies promising new drug to treat cystic fibrosison December 3, 2021 at 12:01 pm
A research lab at Michigan State University is studying the effects of the groundbreaking drug Trikafta on the microbiomes of people with cystic fibrosis.
- Stittsville woman with cystic fibrosis receives game-changing drug after initial denialon November 25, 2021 at 4:06 pm
Unpleasant though the experience was, it told the 23-year-old Stittsville student and cystic fibrosis patient that the life-saving medication she’d started taking that day was working, expelling a ...
- Cystic fibrosis faithfully modeled in a human Lung Airway Chipon November 25, 2021 at 3:08 am
The inherited progressive disorder cystic fibrosis (CF) causes severe damage to the lungs, and other tissues in the body by affecting the cells that produce mucus, sweat, and digestive juices.
via Bing News